Literature DB >> 25031719

IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.

Peng Su1, Jing Hu1, Hui Zhang1, Weiwei Li1, Ming Jia1, Xiaofang Zhang1, Xiaojuan Wu1, Hongxia Cheng1, Lei Xiang1, Gengyin Zhou1.   

Abstract

IMP3 plays an important role in tumor invasion and metastasis, to which epithelial to mesenchymal transition (EMT) also contributes. The purpose of this study was to investigate whether IMP3 can regulate invasion and metastasis through EMT in breast cancers. The protein expression levels of IMP3 and EMT markers were analyzed by immunohistochemistry in 180 paraffin-embedded human breast tissue samples. There was an inverse correlation of IMP3 with E-cadherin protein expression (P = 0.042). IMP3 expression directly correlated with both Slug (P = 0.004) and vimentin (P < 0.001). Changes in E-cadherin, vimentin, and Slug mRNA and protein levels were examined by quantitative real-time reverse polymerase chain reaction (qRT-PCR) and western blotting. Overexpression of IMP3 reduced the expression of E-cadherin and upregulated Slug and vimentin in transfected cells. In contrast, knocking down IMP3 had the opposite expression of the three proteins. Ribo-immunoprecipitation qPCR revealed that IMP3 binds Slug mRNA directly. In a transwell assay, overexpression of Slug rescued the cell migration and invasion caused by silencing IMP3 in MDA-MB-231 cells. On the other hand, knockdown of Slug in T47D-IMP3 cells could also have the opposite change. Our results strengthen the association of IMP3 with the regulation of EMT. Slug is a functional target of IMP3. IMP3 could therefore promote invasion and migration through the EMT in breast cancer cells.

Entities:  

Keywords:  Insulin-like growth factor II (IGF-II) mRNA binding protein 3 (IMP3); breast cancer; epithelial-mesenchymal transition; metastasis; ribo-immunoprecipitation

Mesh:

Substances:

Year:  2014        PMID: 25031719      PMCID: PMC4097240     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Expression of the highly conserved RNA binding protein KOC in embryogenesis.

Authors:  F Mueller-Pillasch; B Pohl; M Wilda; U Lacher; M Beil; C Wallrapp; H Hameister; W Knöchel; G Adler; T M Gress
Journal:  Mech Dev       Date:  1999-10       Impact factor: 1.882

Review 2.  Epithelial-mesenchymal transitions in development and pathologies.

Authors:  Jean Paul Thiery
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

3.  Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome.

Authors:  D Monk; L Bentley; C Beechey; M Hitchins; J Peters; M A Preece; P Stanier; G E Moore
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

Review 4.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

5.  A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.

Authors:  J Nielsen; J Christiansen; J Lykke-Andersen; A H Johnsen; U M Wewer; F C Nielsen
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein.

Authors:  F Müeller-Pillasch; U Lacher; C Wallrapp; A Micha; F Zimmerhackl; H Hameister; G Varga; H Friess; M Büchler; H G Beger; M R Vila; G Adler; T M Gress
Journal:  Oncogene       Date:  1997-06-05       Impact factor: 9.867

7.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

8.  IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression.

Authors:  Sanjoy Samanta; Bryan Pursell; Arthur M Mercurio
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

Review 9.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

10.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

View more
  12 in total

1.  Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry.

Authors:  Cameron M Scott; Ee Ming Wong; JiHoon Eric Joo; Pierre-Antoine Dugué; Chol-Hee Jung; Neil O'Callaghan; James Dowty; Graham G Giles; John L Hopper; Melissa C Southey
Journal:  Exp Mol Pathol       Date:  2018-11-10       Impact factor: 3.362

2.  IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.

Authors:  S Samanta; H Sun; H L Goel; B Pursell; C Chang; A Khan; D L Greiner; S Cao; E Lim; L D Shultz; A M Mercurio
Journal:  Oncogene       Date:  2015-05-18       Impact factor: 9.867

3.  IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.

Authors:  Jinhai Yan; Qingzhu Wei; Wenjing Jian; Bo Qiu; Jing Wen; Jianghuan Liu; Bo Fu; Xinhua Zhou; Tong Zhao
Journal:  Lung       Date:  2015-11-25       Impact factor: 2.584

4.  Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.

Authors:  Akiko Kanzaki; Mitsuhiro Kudo; Shin-Ichi Ansai; Wei-Xia Peng; Kousuke Ishino; Tetsushi Yamamoto; Ryuichi Wada; Takenori Fujii; Kiyoshi Teduka; Kiyoko Kawahara; Yoko Kawamoto; Taeko Kitamura; Seiji Kawana; Hidehisa Saeki; Zenya Naito
Journal:  Int J Oncol       Date:  2016-01-05       Impact factor: 5.650

5.  Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.

Authors:  Luyao Chen; Yongpeng Xie; Xintao Li; Liangyou Gu; Yu Gao; Lu Tang; Jianwen Chen; Xu Zhang
Journal:  Onco Targets Ther       Date:  2017-06-06       Impact factor: 4.147

6.  Prognostic significance of IMP-3 expression pattern in esophageal squamous cell carcinoma.

Authors:  Terue Sakakibara; Soji Ozawa; Junya Oguma; Minoru Nakui; Soichiro Yamamoto; Hiroyasu Makuuchi; Hiroshi Kajiwara; Naoya Nakamura
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 7.  The biological function of IGF2BPs and their role in tumorigenesis.

Authors:  Qiu-Ying Du; Zhi-Man Zhu; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-07-12       Impact factor: 3.850

Review 8.  The emerging role of RNA N6-methyladenosine methylation in breast cancer.

Authors:  Fangchao Zheng; Feng Du; Jiuda Zhao; Xue Wang; Yiran Si; Peng Jin; Haili Qian; Binghe Xu; Peng Yuan
Journal:  Biomark Res       Date:  2021-05-27

9.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.

Authors:  Wei Zhao; Dan Lu; Liang Liu; Juan Cai; Yu Zhou; Ying Yang; Yu Zhang; Jun Zhang
Journal:  Oncotarget       Date:  2017-09-27

10.  Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.

Authors:  Jacek M Kwiecien; Blessing I Bassey-Archibong; Wojciech Dabrowski; Lyndsay G Rayner; Alexandra R Lucas; Juliet M Daniel
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.